Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 133.32 USD -1.39% Market Closed
Market Cap: 231.2B USD

EV/EBITDA
Enterprise Value to EBITDA

22.2
Current
19
Median
11.5
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
22.2
=
Enterprise Value
235.5B USD
/
EBITDA
10.6B USD

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
19.7
2-Years Forward
EV/EBITDA
18
3-Years Forward
EV/EBITDA
16.3